Showing results (61-70 of 66) with videos related to
Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Nature Medicine|November 26, 2008
Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysisWen-Hung Chung, Shuen-Iu Hung, Jui-Yung Yang, et al.Breast Cancer Research and Treatment|April 28, 2021
Neratinib + capecitabine sustains health-related quality of life in patients with HER2-positive metastatic breast cancer and ≥ 2 prior HER2-directed regimensBeverly Moy, Mafalda Oliveira, Cristina Saura, et al.Cytometry. Part B, Clinical Cytometry|November 23, 2022
Multicenter prospective evaluation of diagnostic potential of flow cytometric aberrancies in myelodysplastic syndromes by the ELN iMDS flow working groupWolfgang Kern, Theresia M Westers, Frauke Bellos, et al.Breast Cancer Research and Treatment|September 23, 2021
Analysis of the pan-Asian subgroup of patients in the NALA Trial: a randomized phase III NALA Trial comparing neratinib+capecitabine (N+C) vs lapatinib+capecitabine (L+C) in patients with HER2+metastatic breast cancer (mBC) previously treated with two or more HER2-directed regimensMing Shen Dai, Yin Hsun Feng, Shang Wen Chen, et al.Haematologica|October 21, 2016
Immunophenotypic analysis of erythroid dysplasia in myelodysplastic syndromes. A report from the IMDSFlow working groupTheresia M Westers, Eline M P Cremers, Uta Oelschlaegel, et al.Journal of Breast Cancer|July 6, 2026
2025 Update of the Taiwan Expert Consensus on Hormone Receptor-Positive Metastatic Breast Cancer ManagementJiun-I Lai, Chih-Chiang Hung, Chin-Yao Lin, et al.Pageof 7